These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19513421)

  • 1. Oxidative modification of fibrinogen inhibits its transformation into fibrin under the effect of thrombin.
    Azizova OA; Piryazev AP; Aseychev AV; Shvachko AG
    Bull Exp Biol Med; 2009 Feb; 147(2):201-3. PubMed ID: 19513421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oxidation-modified fibrinogen on the formation and lysis of fibrin clot in the plasma.
    Piryazev AP; Aseichev AV; Azizova OA
    Bull Exp Biol Med; 2009 Dec; 148(6):881-5. PubMed ID: 21116496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin self-assembly is adapted to oxidation.
    Rosenfeld MA; Bychkova AV; Shchegolikhin AN; Leonova VB; Kostanova EA; Biryukova MI; Sultimova NB; Konstantinova ML
    Free Radic Biol Med; 2016 Jun; 95():55-64. PubMed ID: 26969792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
    Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thrombin-fibrinogen interaction.
    Scheraga HA
    Biophys Chem; 2004 Dec; 112(2-3):117-30. PubMed ID: 15572239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coarse-grained molecular dynamics simulations of fibrin polymerization: effects of thrombin concentration on fibrin clot structure.
    Yesudasan S; Wang X; Averett RD
    J Mol Model; 2018 Apr; 24(5):109. PubMed ID: 29623504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.
    Haynes LM; Orfeo T; Mann KG; Everse SJ; Brummel-Ziedins KE
    Biophys J; 2017 Apr; 112(8):1634-1644. PubMed ID: 28445754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation.
    Mosesson MW
    Thromb Haemost; 2003 Jan; 89(1):9-12. PubMed ID: 12540947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking oxidation-induced alterations in fibrin clot formation by NMR-based methods.
    Lau WH; White NJ; Yeo TW; Gruen RL; Pervushin K
    Sci Rep; 2021 Aug; 11(1):15691. PubMed ID: 34344919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation.
    Shacter E; Williams JA; Levine RL
    Free Radic Biol Med; 1995 Apr; 18(4):815-21. PubMed ID: 7750804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conversion of fibrinogen to fibrin: A brief history of some key events.
    Doolittle RF
    Matrix Biol; 2017 Jul; 60-61():5-7. PubMed ID: 27519977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of critical residues on thrombin mediating its interaction with fibrin.
    Hall SW; Gibbs CS; Leung LL
    Thromb Haemost; 2001 Dec; 86(6):1466-74. PubMed ID: 11776315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis.
    Vucelic D; Jesic R; Jovicic S; Zivotic M; Grubor N; Trajkovic G; Canic I; Elezovic I; Antovic A
    Thromb Res; 2015 Jun; 135(6):1124-30. PubMed ID: 25900310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full and partial deuterium solvent isotope effect studies of alpha-thrombin-catalyzed reactions of natural substrates.
    Zhang D; Kovach IM
    J Am Chem Soc; 2005 Mar; 127(11):3760-6. PubMed ID: 15771510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.